1. Inactive Parp2 causes Tp53-dependent lethal anemia by blocking replication-associated nick ligation in erythroblasts.
- Author
-
Lin, Xiaohui, Gupta, Dipika, Vaitsiankova, Alina, Bhandari, Seema Khattri, Leung, Kay Sze Karina, Menolfi, Demis, Lee, Brian J., Russell, Helen R., Gershik, Steven, Huang, Xiaoyu, Gu, Wei, McKinnon, Peter J., Dantzer, Françoise, Rothenberg, Eli, Tomkinson, Alan E., and Zha, Shan
- Subjects
- *
REPLICATION fork , *DNA damage , *POLY(ADP-ribose) polymerase , *CHECKPOINT kinase 2 , *ERYTHROPOIESIS , *POLY ADP ribose - Abstract
Poly (ADP-ribose) polymerase (PARP) 1 and 2 enzymatic inhibitors (PARPi) are promising cancer treatments. But recently, their use has been hindered by unexplained severe anemia and treatment-related leukemia. In addition to enzymatic inhibition, PARPi also trap PARP1 and 2 at DNA lesions. Here we report that, unlike Parp2 −/− mice, which develop normally, mice expressing catalytically inactive Parp2 (E534A and Parp2 EA/EA ) succumb to Tp53 - and Chk2 -dependent erythropoietic failure in utero , mirroring Lig1 −/− mice. While DNA damage mainly activates PARP1, we demonstrate that DNA replication activates PARP2 robustly. PARP2 is selectively recruited and activated by 5′-phosphorylated nicks (5′p-nicks), including those between Okazaki fragments, resolved by ligase 1 (Lig1) and Lig3. Inactive PARP2, but not its active form or absence, impedes Lig1- and Lig3-mediated ligation, causing dose-dependent replication fork collapse, which is detrimental to erythroblasts with ultra-fast forks. This PARylation-dependent structural function of PARP2 at 5′p-nicks explains the detrimental effects of PARP2 inactivation on erythropoiesis, shedding light on PARPi-induced anemia and the selection for TP53/CHK2 loss. [Display omitted] • PARP2 is activated during normal erythroblastocyte replication by 5′p-nicks • Inactive PARP2 protein, but not the absence of PARP2, interferes with DNA replication • The presence of inactive PARP2 blocks erythropoiesis, leading to lethal anemia This work shows that the hematological toxicities associated with PARP inhibitors stem not from impaired PARP1 or PARP2 enzymatic activity but rather from the presence of inactive PARP2 protein. Mechanistically, these toxicities reflect a unique role of PARP2 at 5′-phosphorylated DNA nicks during DNA replication in erythroblasts. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF